Product Information
BROMPHEN-PSE-DM 2-30-10 MG/5 ML is a generic product labeled by Acella Pharmaceuticals, LLC, priced at $0.0818 per ML under NDC 42192063004. Its NADAC has been published 61 times since Aug 6, 2025.
FDA first approved this application on Sep 20, 2016. Its Orange Book therapeutic-equivalence code is AA.
BROMPHEN-PSE-DM 2-30-10 MG/5 ML
Brompheniramine Maleate, Pseudoephedrine Hydrochloride, and Dextromethorphan HydrobromideStrength
2; 10; 30 mg/5mL; mg/5mL; mg/5mL
Manufacturer
Acella Pharmaceuticals, LLCNDC
42192063004
Classification
Generic
Dosage Form
SYRUP
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PSEUDOEPHEDRINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA203375FDA Approved
9/20/2016
TE Code
AA
On Market Since
2/1/2025
Pharmacological Classes
Price Statistics
The NADAC for BROMPHEN-PSE-DM 2-30-10 MG/5 ML has been published 61 times since Aug 6, 2025, and over the history we have for it it has risen 3.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0818 per ML |
|---|---|
| All-time high | $0.0868 (Dec 10, 2025) |
| All-time low | $0.0744 (May 20, 2026) |
| 52-week high | $0.0868 |
| 52-week low | $0.0744 |
| Median price | $0.0798 |
| Average price | $0.0798 |
| Largest weekly change | -7.6% (Dec 17, 2025) |
| Weeks tracked | 61 |
| Tracking since | Aug 6, 2025 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 17% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Acella Pharmaceuticals, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Brompheniramine Maleate, Pseudoephedrine Hydrochloride, and Dextromethorphan Hydrobromide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Sigma-1 Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BROMPHEN-PSE-DM 2-30-10 MG/5 ML?
The current National Average Drug Acquisition Cost (NADAC) for BROMPHEN-PSE-DM 2-30-10 MG/5 ML, manufactured by Acella Pharmaceuticals, LLC, is $0.0818 per ML (NDC 42192063004), effective Sep 30, 2026.
How has the price of BROMPHEN-PSE-DM 2-30-10 MG/5 ML changed over time?
Over the history we have for it, the NADAC for BROMPHEN-PSE-DM 2-30-10 MG/5 ML has risen 3.3%. It has been tracked across 61 weekly CMS publications since Aug 6, 2025.
What are the highest and lowest recorded NADAC prices for BROMPHEN-PSE-DM 2-30-10 MG/5 ML?
Since Aug 6, 2025, the NADAC for BROMPHEN-PSE-DM 2-30-10 MG/5 ML has ranged from a low of $0.0744 (May 20, 2026) to a high of $0.0868 (Dec 10, 2025), with a median of $0.0798 per ML.
Are there cheaper alternatives to BROMPHEN-PSE-DM 2-30-10 MG/5 ML?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BROMPHEN-PSE-DM 2-30-10 MG/5 ML, is $0.0682 per ML — about 17% below BROMPHEN-PSE-DM 2-30-10 MG/5 ML.
Who manufactures BROMPHEN-PSE-DM 2-30-10 MG/5 ML?
BROMPHEN-PSE-DM 2-30-10 MG/5 ML (NDC 42192063004) is labeled by Acella Pharmaceuticals, LLC, and CMS classifies it as a generic product.